Streetbeat News

AUGG

Augusta Gold Corp.

http://www.bullfroggoldcorp.com/

CEO

David Beling

Employees

7

Industry

Dimension Stone Mining and Quarrying

Open

0.76

Mkt cap

65M

Volume

6.4K

High

0.77

P/E Ratio

-12.67

52-wk high

0.93

Low

0.76

Div yield

N/A

52-wk low

0.38

Insiders are buying shares of penny stocks Augusta Gold, Stemtech, and Pineapple Financial. This insider activity may indicate confidence in these companies' prospects. Augusta Gold's Executive Chairman bought 15,000 shares, Stemtech's Director acquired 25,000 shares, and Pineapple Financial's COO purchased 4,000 shares.

Portfolio Pulse from Avi Kapoor

August 01, 2024 | 5:20 pm

Insiders at Palatin Technologies, Tecogen, and Augusta Gold have recently made significant stock purchases, signaling potential confidence in their companies' futures. Tecogen's Director acquired shares at $0.70 each, following a reported revenue of $5.9 million and a net loss for the last quarter of 2023. Augusta Gold's Executive Chairman bought shares at $0.81 each after the company named an interim CFO. Palatin Technologies saw a Director purchase shares at $2.12 each, subsequent to announcing promising results from a Phase 3 trial for a dry eye disease treatment.

Portfolio Pulse from Avi Kapoor

April 12, 2024 | 12:36 pm

Insiders at four companies, Glatfelter Corporation (GLT), Dalrada Financial Corporation (DFCO), Lexicon Pharmaceuticals, Inc. (LXRX), and Augusta Gold Corp. (AUGG), have recently made significant share purchases. Glatfelter's 10% owner acquired 236,000 shares, Dalrada's CEO bought 7,300 shares, a director at Lexicon purchased 1,000,000 shares, and Augusta's Executive Chairman bought 15,000 shares. These transactions may indicate the insiders' confidence in their respective companies' prospects.

Portfolio Pulse from Lisa Levin

October 13, 2023 | 12:06 pm

Insiders at four penny stocks, Dalrada Financial Corporation (OTC:DFCO), Gaia, Inc. (NASDAQ:GAIA), Cidara Therapeutics, Inc. (NASDAQ:CDTX), and Augusta Gold Corp. (OTC:AUGG), have recently made notable purchases. Dalrada's CEO acquired 15,000 shares, Gaia's Director bought 9,000 shares, Cidara's President and CEO purchased 50,000 shares, and Augusta's Executive Chairman bought 30,000 shares. These transactions may indicate the insiders' confidence in their companies' prospects.

Portfolio Pulse from Lisa Levin

August 09, 2023 | 12:53 pm

Insiders at four companies have recently made notable purchases of their own stocks. Scott's Liquid Gold-Inc. (OTC:SLGD) Director Daniel Roller acquired 794,067 shares, Augusta Gold Corp. (OTC:AUGG) Executive Chairman Richard Warke bought 5,000 shares, Galectin Therapeutics Inc. (NASDAQ:GALT) Director Kary Eldred purchased 1,598 shares, and Earth Science Tech, Inc. (OTC:ETST) CEO Giorgio R Saumat acquired 50,002 shares.

Portfolio Pulse from Lisa Levin

July 21, 2023 | 11:24 am

Insiders at Evelo Biosciences, Dalrada Financial Corporation, and Augusta Gold Corp. have recently made significant purchases of their companies' stocks. Noubar Afeyan, a 10% owner of Evelo Biosciences, acquired 5,411,255 shares at an average price of $2.31, costing around $12.5 million. Brian Bonar, CEO of Dalrada Financial, bought 79,550 shares at an average price of $0.14, spending around $11,510. Richard Warke, Executive Chairman of Augusta Gold, purchased 10,000 shares at an average price of $0.78, costing around $7,750.

Portfolio Pulse from Lisa Levin

July 14, 2023 | 11:30 am

Insiders at AlloVir, Inc. (NASDAQ:ALVR), Augusta Gold Corp. (OTC:AUGG), and Holley Inc. (NYSE:HLLY) have recently made significant purchases of their companies' stocks. Gilead Sciences Inc, a 10% owner of AlloVir, acquired nearly 3 million shares at an average price of $3.75, costing around $10.99 million. Augusta Gold's Executive Chairman Richard Warke bought 50,000 shares at an average price of $0.64, spending around $32,000. Edward Virtue, a 10% owner of Holley, acquired over 4,000 shares at an average price of $3.50, costing around $14,343.

Portfolio Pulse from Lisa Levin

June 29, 2023 | 10:15 am

Insiders at Emeren Group, Augusta Gold, and Arena Group Holdings have been aggressively buying shares, indicating confidence in the companies' prospects. Emeren Group reported a rise in quarterly sales, Augusta Gold advanced reward feasibility study and issued an operational update, and Arena Group posted a narrower-than-expected quarterly loss.

Portfolio Pulse from Lisa Levin

June 26, 2023 | 11:37 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.